University of Alberta
π¨π¦Canada
- Country
- π¨π¦Canada
- Ownership
- Private
- Established
- 1908-01-01
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.ualberta.ca
Transcutaneous Bilirubinometers in the Community
Not Applicable
Completed
- Conditions
- Jaundice, Neonatal
- Interventions
- Device: Transcutaneous Bilirubinometer
- First Posted Date
- 2008-08-14
- Last Posted Date
- 2010-01-12
- Lead Sponsor
- University of Alberta
- Target Recruit Count
- 10000
- Registration Number
- NCT00735319
- Locations
- π¨π¦
Sturgeon Community Hospital, Edmonton, Alberta, Canada
π¨π¦WestView Health Centre, Stony Plain, Alberta, Canada
π¨π¦Fort Saskatchewan Health Centre, Fort Saskatchewan, Alberta, Canada
L-arginine in Treatment as Usual in Schizophrenia
- First Posted Date
- 2008-07-18
- Last Posted Date
- 2017-09-05
- Lead Sponsor
- University of Alberta
- Target Recruit Count
- 13
- Registration Number
- NCT00718510
- Locations
- π¨π¦
Alberta Hospital Edmonton, Edmonton, Alberta, Canada
Assessment of Biomarkers for Recurrent HCV Infection Post-liver Transplantation
Completed
- Conditions
- Hepatitis C Virus
- First Posted Date
- 2008-07-04
- Last Posted Date
- 2011-09-15
- Lead Sponsor
- University of Alberta
- Target Recruit Count
- 40
- Registration Number
- NCT00710801
- Locations
- π¨π¦
University of Alberta Hospital, Edmonton, Alberta, Canada
Families First Edmonton (FFE)
Phase 2
Completed
- Conditions
- Low-Income Population
- Interventions
- Behavioral: Primary Health Care Model (PRMHLTH)Behavioral: Comprehensive Model (COMP)Behavioral: Recreation Coordination Model (REC)
- First Posted Date
- 2008-06-26
- Last Posted Date
- 2016-04-21
- Lead Sponsor
- University of Alberta
- Target Recruit Count
- 2400
- Registration Number
- NCT00705328
- Locations
- π¨π¦
Alberta Human Resources and Employment, Edmonton, Alberta, Canada
Intron A for the Treatment of Hypertrophic Scar
Phase 3
Withdrawn
- Conditions
- BurnHypertrophic Scar
- Interventions
- Drug: interferon alpha 2b
- First Posted Date
- 2008-05-29
- Last Posted Date
- 2014-01-30
- Lead Sponsor
- University of Alberta
- Registration Number
- NCT00686478
- Locations
- π¨π¦
University of Alberta, Edmonton, Alberta, Canada
Adalimumab for Inflammatory Osteoarthritis
- First Posted Date
- 2008-05-29
- Last Posted Date
- 2012-06-14
- Lead Sponsor
- University of Alberta
- Target Recruit Count
- 20
- Registration Number
- NCT00686439
- Locations
- π¨π¦
The University of Alberta Hospital, Edmonton, Alberta, Canada
Cell-mediated Immune Response to Influenza Vaccine
Completed
- Conditions
- Kidney Transplant
- First Posted Date
- 2008-05-14
- Last Posted Date
- 2011-09-14
- Lead Sponsor
- University of Alberta
- Target Recruit Count
- 100
- Registration Number
- NCT00677547
- Locations
- π¨π¦
University of Alberta Hospital, Edmonton, Alberta, Canada
Safety and Immunogenicity of Human Papillomavirus (HPV) Vaccine in Solid Organ Transplant Recipients
Phase 3
Completed
- Conditions
- Transplant
- First Posted Date
- 2008-05-14
- Last Posted Date
- 2015-01-01
- Lead Sponsor
- University of Alberta
- Target Recruit Count
- 50
- Registration Number
- NCT00677677
- Locations
- π¨π¦
University of Alberta Hospital, Edmonton, Alberta, Canada
Cytomegalovirus (CMV) MicroRNA Expression in Vivo and Immune Evasion Correlates
Completed
- Conditions
- Transplant
- First Posted Date
- 2008-05-14
- Last Posted Date
- 2022-06-01
- Lead Sponsor
- University of Alberta
- Target Recruit Count
- 47
- Registration Number
- NCT00677482
- Locations
- π¨π¦
University of Alberta Hospital, Edmonton, Alberta, Canada
In-home Telerehabilitation for Quadriplegic Hand Function
Phase 2
Completed
- Conditions
- Spinal Cord InjuryQuadriplegiaTetraplegia
- Interventions
- Procedure: Telerehabilitation of hand functionProcedure: Conventional exercise therapy
- First Posted Date
- 2008-04-10
- Last Posted Date
- 2017-01-12
- Lead Sponsor
- University of Alberta
- Target Recruit Count
- 13
- Registration Number
- NCT00656149
- Locations
- π¨π¦
Centre for Neuroscience, University of Alberta, Edmonton, Alberta, Canada
Β© Copyright 2025. All Rights Reserved by MedPath